NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Holders of 5% or more of NBP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of NovaBridge Biosciences, largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on NovaBridge Biosciences, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 20254:57 PM ET | CBC Investment I-Mab Ltdand 11 others | 13D/A | 10.40%27.5M shares | −7.50 ppfrom 17.90% | Aug 5, 2025 | SEC |
| Aug 5, 20254:00 PM ET | Everest Medicines Ltd | 13D | 16.10%42.5M shares | New | Aug 5, 2025 | SEC |
| Feb 5, 20258:09 PM ET | CBC Investment I-Mab Ltdand 12 others | 13D | 17.90%33.6M shares | New | Jan 29, 2025 | SEC |
| Feb 6, 20248:55 PM ET | Infini Capital Management Ltd | 13G | 0.00%0 shares | NewBelow 5% | Dec 31, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell NovaBridge Biosciences shares.
No Form 144 notices for NovaBridge Biosciences are on file.